Rafferty Asset Management’s Prelude Therapeutics PRLD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-36,936	Closed	-$1.15M	–	1325
2021 Q3	$1.15M	Sell	36,936 -12,844	-26%	-$401K	0.01%	777
2021 Q2	$1.43M	Buy	49,780 +1,330	+3%	+$38.1K	0.01%	779
2021 Q1	$2.1M	Buy	+48,450	New	+$2.1M	0.01%	609